Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suvorexant as an Adjunct to Buprenorphine Induction and Maintenance in Persons Who Use Fentanyl

NCT05145764 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05145764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05145764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suvorexant as an Adjunct to Buprenorphine Induction and Maintenance in Persons Who Use Fentanyl
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
March 30, 2022
Completion date
August 3, 2026
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder, placebo, suvorexant